Investitionsthese
Cambridge Enterprise is the University of Cambridge’s innovation and commercialization arm, supporting research translation through venture building and investment.
Investitionsphase
Seed funding and early-stage investment
Bevorzugte Reifephase für die erste Finanzierung.
Sektoren & Themen
Supporting the translation of Cambridge research into commercial ventures, including spinouts, academic consultancy, and social enterprises.
Thematische Schwerpunkte und Zielmarktsegmente von Interesse.
Ticketgröße
€1.771.000 - €2.542.000
Standard-Finanzierungsbetrag pro Runde.
Outreach & Dossier-Analysen
Verifiziertes E-Mail-Muster
Analysen-Scorecard der Investitionsthese
Unser KI-Analyzer hat Portfolio-Unternehmen gescannt und verifizierte Übereinstimmungen berechnet...
Investment Team (31)
A
Akriti Dokania
Partner
A
Amanda Wooding
Deputy Head of Ventures
A
Andy Sandham
Deputy Chair, Investment Committee
A
Annalisa Gigante
Investment Committee Member
C
Chris Gibbs
Investment Director
C
Christine Martin
Head of Ventures
D
Declan Weldon
Head of Technology Development & Licensing
D
Dr Amanda Wooding
Deputy Head of Ventures
D
Dr Barbara Domayne-Hayman
Investment Committee Member
D
Dr Gemma Siddall
Senior Investment Associate (Sustainability)
D
Dr Iris Good
Investment Committee Member
D
Dr Jason Amartey
Investment Analyst
D
Dr Stefan Galander
Investment Associate
D
Dr Tom Mentlak
Head of Technology Investment Fund
D
Dr Vishal Gulati
Investment Committee Member
D
Dr. Keith
Investor Director
F
Fátima Kranc
Investment Manager (Life Sciences)
G
Gemma Siddall
Senior Investment Associate (Sustainability)
J
Jason Amartey
Investment Analyst
J
Jim Glasheen
Chief Executive Officer
J
John Halfpenny
Investment Committee Member
J
John Lee
Chairman of Cambridge Enterprise's Investment Committee
M
Mahesh Santiapillai
Investment Manager (Software & DeepTech)
M
Megan Meredith-Rodriguez
Investment Associate (Deep Tech)
P
Pam Garside
Investment Committee Member
P
Phil Elstob
Commercialisation Director, Deputy Head of Life Sciences
P
Piers Horlock
Investment Associate
P
Polly Machin
Senior Investment Associate
S
Stefan Galander
Investment Associate
T
Terry Parlett
Commercialisation Director, Deputy Head of Life Sciences
T
Tom Mentlak
Head of Technology Investment Fund
